Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P44
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -0.16% |
| Q3 2025 | 1.30% |
| Q2 2025 | -8.16% |
| Q1 2025 | 1.43% |
| Q4 2024 | 27.46% |
| Q3 2024 | 7.57% |
| Q2 2024 | 75.27% |
| Q1 2024 | -33.20% |
| Q4 2023 | 213.26% |
| Q3 2023 | -181.47% |
| Q2 2023 | 27.71% |
| Q1 2023 | 16.08% |
| Q4 2022 | 11.97% |
| Q3 2022 | 5.22% |
| Q2 2022 | 63.27% |
| Q1 2022 | 42.24% |
| Q4 2021 | -9.88% |
| Q3 2021 | -15.20% |
| Q2 2021 | 58.96% |
| Q1 2021 | -33.00% |
| Q4 2020 | -73.61% |
| Q3 2020 | 343.15% |
| Q2 2020 | -6.20% |
| Q1 2020 | 31.48% |
| Q4 2019 | -41.82% |
| Q3 2019 | 24.36% |
| Q2 2019 | 1800.53% |
| Q1 2019 | 95.56% |
| Q4 2018 | -84.97% |
| Q3 2018 | -31.41% |
| Q2 2018 | -4.65% |
| Q1 2018 | -5.79% |
| Q4 2017 | -28.96% |
| Q3 2017 | -7.67% |
| Q2 2017 | 21.89% |
| Q1 2017 | -19.31% |
| Q4 2016 | -5.29% |
| Q3 2016 | 13.46% |
| Q2 2016 | 15.17% |
| Q1 2016 | 7.38% |